Serum Level of PD-1, PD-L1, and PD-L2 as a New Biomarker for Esophageal Cancer

被引：1
|
作者：
Akutsu, Yasunori [1 ]
Murakami, Kentaro [1 ]
Hanari, Naoyuki [1 ]
Kano, Masayuki [1 ]
Uesato, Masaya [1 ]
Ota, Takumi [1 ]
Suito, Hiroshi [1 ]
Matsumoto, Yasunori [1 ]
Takahashi, Masahiko [1 ]
Matsubara, Hisahiro [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Frontier Surg, Chiba, Japan
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-01622
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1622
引用
收藏
页码：S694 / S694
页数：1
相关论文
共 50 条
  • [21] PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population
    Karolova, J.
    Radek, M.
    Helman, K.
    Spacek, M.
    Trneny, M.
    Klener, P.
    FOLIA BIOLOGICA, 2020, 66 (04) : 117 - 122
  • [22] Patterns of PD-1 PD-L1 and PD-L2 expression in pediatric solid tumors.
    Pinto, Navin R.
    Park, Julie R.
    Murphy, Erin
    Yearley, Jennifer
    McClanahan, Terri
    Annamalai, Lakshmanan
    Hawkins, Douglas S.
    Rudzinski, Erin R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival
    Liu, Jingwei
    Li, Hao
    Sun, Liping
    Yuan, Yuan
    Xing, Chengzhong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [24] Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer
    Mo, Zhongfu
    Liu, Jing
    Zhang, Qiuyang
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Yang, Shijie
    Li, Huina
    Zhou, Lifei
    You, Zongbing
    ONCOLOGY LETTERS, 2016, 12 (02) : 944 - 950
  • [25] Identification of PD-1 ligands: PD-L1 and PD-L2 on macrophages in lung cancer milieu by flow cytometry
    Kwiecien, Iwona
    Rutkowska, Elzbieta
    Polubiec-Kownacka, Malgorzata
    Raniszewska, Agata
    Rzepecki, Piotr
    Domagala-Kulawik, Joanna
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (04) : 1679 - 1689
  • [26] Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis
    Javan, Mohammad Reza
    Aslani, Saeed
    Zamani, Mohammad Reza
    Rostamnejad, Javad
    Asadi, Milad
    Farhoodi, Mahdi
    Nicknam, Mohammad Hossein
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2016, 15 (04) : 296 - 302
  • [27] INTRAHEPATIC EXPRESSION OF PD-1, PD-L1 AND PD-L2 IN CHRONIC HEPATITIS B PATIENTS
    Chen, J.
    Lan, M. -D.
    Wu, X. -J.
    Zhao, J. -M.
    Lan, Z. -W.
    Wang, G-Q
    JOURNAL OF HEPATOLOGY, 2009, 50 : S205 - S205
  • [28] Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer
    Jeong, Seri
    Lee, Nuri
    Park, Min-Jeong
    Jeon, Kibum
    Song, Wonkeun
    CANCERS, 2021, 13 (20)
  • [29] Prognostic significance of PD-L1 and PD-L2 in breast cancer
    Baptista, Mauricio Z.
    Sarian, Luis Otavio
    Derchain, Sophie F. M.
    Pinto, Glauce A.
    Vassal, Jose
    HUMAN PATHOLOGY, 2016, 47 (01) : 78 - 84
  • [30] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
12345